Muutke küpsiste eelistusi

RNA Interference and Cancer Therapy: Methods and Protocols 2019 ed. [Kõva köide]

  • Formaat: Hardback, 416 pages, kõrgus x laius: 254x178 mm, kaal: 1028 g, 84 Illustrations, color; 28 Illustrations, black and white; XIII, 416 p. 112 illus., 84 illus. in color., 1 Hardback
  • Sari: Methods in Molecular Biology 1974
  • Ilmumisaeg: 17-May-2019
  • Kirjastus: Humana Press Inc.
  • ISBN-10: 1493992198
  • ISBN-13: 9781493992195
Teised raamatud teemal:
  • Kõva köide
  • Hind: 141,35 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 166,29 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 416 pages, kõrgus x laius: 254x178 mm, kaal: 1028 g, 84 Illustrations, color; 28 Illustrations, black and white; XIII, 416 p. 112 illus., 84 illus. in color., 1 Hardback
  • Sari: Methods in Molecular Biology 1974
  • Ilmumisaeg: 17-May-2019
  • Kirjastus: Humana Press Inc.
  • ISBN-10: 1493992198
  • ISBN-13: 9781493992195
Teised raamatud teemal:
This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense ‘bench to bedside’ potential of RNAi as a therapeutic molecule, the book focuses many of its chapters on nanoparticle-based targeted deliveries, including aptamers, as well as techniques for using RNAi technology to combat various cancers in preclinical studies. Each of the 26 chapters is authored by the pioneers in the respective areas and thus provides a practical and empirical account of the techniques that could be used as benchmark tools in the area of cancer research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. 

Authoritative and essential, RNA Interference and Cancer Therapy: Methods and Protocols provides the necessary guidance for both novice and professional researchers who intend to discover and innovate newer means of using RNAi technology to combat cancer, one of the greatest scourges of human health.
Preface v
Contributors ix
1 siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple-Negative Breast Cancer Cells
1(20)
Bindu Thapa
K.C. Remant
Hasan Uludag
2 In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy
21(10)
Xing Fei Tan
Wei Xuan Teo
George W. Yip
3 siRNA-Based Drug Targeting Human Bcl-xL Against Cancers
31(10)
Yoshifumi Takei
4 Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs
41(16)
Phillip A. Angart
Kwasi Adu-Berchie
Rebecca J. Carlson
Daniel B. Vocelle
Christina Chan
S. Patrick Walton
5 VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier
57(12)
Anna A. Egorova
Marianna A. Maretina
Anton V. Kiselev
6 Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" That Can Conditionally Release Their Cargo
69(14)
Katherine E. Bujold
Hassan H. Fakih
Hanadi F. Sleiman
7 Combinatorial siRNA Polyplexes for Receptor Targeting
83(16)
Dian-fang Lee
Ernst Wagner
8 Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy
99(12)
Daniel F. Costa
Can Sarisozen
Vladimir P. Torchilin
9 Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol
111(30)
Mehul Jivrajani
Manish Nivsarkar
10 Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo
141(10)
Yu-Lin Su
Piotr Swiderski
Guido Marcucci
Marcin Kortylewski
11 Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles
151(10)
Inbal Hazan-Halevy
Daniel Rosenblum
Srinivas Ramishetti
Dan Peer
12 Targeting Cancer with Peptide RNAi Nanoplexes
161(20)
A. Fames Mixson
Qixin Leng
Szu-Ting Chou
Martin C. Woodle
13 Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles
181(14)
Christine Vauthier
14 Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery
195(8)
Hitesh Kulhari
Ashok K. Jangid
David J. Adams
15 Synthesis of Gold Nanoparticles for Gene Silencing
203(12)
Claudia Tortiglione
Jesus M. de la Fuente
16 Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment
215(8)
Deep Pooja
Ramakrishna Sistla
17 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery
223(10)
Lei Kang
Zachary T. Rosenkrans
Weibo Cai
18 Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer
233(12)
Hiroaki Taniguchi
Kohzob Imai
19 Biodrug Suppresses Breast and Colorectal Cancer in Murine Models
245(20)
Syed Sultan Beevi
Naveen Kumar Tangudu
Vinod Kumar Verma
Lekha Dinesh Kumar
20 Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment
265(26)
Rebaz Ahmed
Narsireddy Amreddy
Anish Babu
Anupama Munshi
Rajagopal Ramesh
21 Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells
291(12)
Kamil Rahme
Jianfeng Guo
Justin D. Holmes
22 Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation
303(26)
Gulay Buyukkdroglu
Behiye Senel
Evrim Tenilmez
23 The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models
329(26)
Joshua A. McCarroll
George Sharbeen
Maria Kavallaris
Phoebe A. Phillips
24 Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer
355(16)
Daniel P. Feldmann
Steven Jones
Kirk Douglas
Anthony F. Shields
Olivia M. Merkel
25 Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma
371(22)
Serena Tommasini-Ghelfi
Andrew Lee
Chad A. Mirkin
Alexander H. Stegh
26 Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy
393(16)
Leyuan Xu
Hu Tang
Index 409